Kaposi's sarcoma staging

Jump to navigation Jump to search

Kaposi's sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kaposi's sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Kaposi's sarcoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kaposi's sarcoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kaposi's sarcoma staging

CDC on Kaposi's sarcoma staging

Kaposi's sarcoma staging in the news

Blogs on Kaposi's sarcoma staging

Directions to Hospitals Treating Kaposi's sarcoma

Risk calculators and risk factors for Kaposi's sarcoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [3]

Overview

There is no established system for the staging of Kaposi's sarcoma among immune competent patients. However, the staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, patients immune status, and the presence of any systemic illness.

Staging

  • There is no established system for the staging of Kaposi's sarcoma among immune competent patients.
  • The staging of AIDS-associated Kaposi's sarcoma is based on the AIDS Clinical Trials Group (ACTG) staging system. According to the ACTG staging system, there are 2 groups of AIDS-associated Kaposi's sarcoma based on the tumor size, patients immune status, and the presence of any systemic illness.[1][2][3][4][5]
Factors Good Risk (Subscript 0) Poor Risk (Subscript 1)

Tumor (T)

Immune system (I)

Systemic illness (S)

  • No previous history of opportunistic infection or thrush
  • B symptoms are not present
  • Karnofsky performance status score ≥ 70
  • Early stage groups, which are associated with a good risk, include T0I0S0.
  • Advanced stage groups, which are associated with a poor risk, include any combination of the TIS system that is not T0I0S0. For example, poor risk groups include T1I0S0, T1I1S0, T1I0S1, T1I1S0, T0I1S0, T1I1S1, etc. Thus, any poor risk feature in the TIS staging system places a patient into the poor risk category overall.

References

  1. Kaposi Sarcoma Treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq#section/_15 Accessed on January, 20 2015
  2. Krown SE, Metroka C, Wernz JC (1989). "Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 7 (9): 1201–7. PMID 2671281.
  3. Krown SE, Testa MA, Huang J (1997). "AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee". J Clin Oncol. 15 (9): 3085–92. PMID 9294471.
  4. Sarcoma- Kaposi Guide. Cancer.Net (2015) http://www.cancer.net/cancer-types/sarcoma-kaposi/risk-factors-and-prevention Accessed on January, 20 2015
  5. How is Kaposi sarcoma staged? American Cancer Association (2015) http://www.cancer.org/cancer/kaposisarcoma/detailedguide/kaposi-sarcoma-staging Accessed on January, 20 2016


Template:WH Template:WS